|
| Brand Name: | LIBANG |
| MOQ: | 10,000 packs |
| Price: | to be negotiated |
| Payment Terms: | T/T, L/C |
| Supply Ability: | 200000 ampoules per year |
Sodium Hyaluronate Injection 10mg/mL
FOR INTRAOCULAR ADMINISTRATION
Rx Only
DESCRIPTION
Sodium Hyaluronate Injection is a sterile, nonpyrogenic, viscoelastic preparation of a highly purified, noninflammatory, high molecular weight fraction of sodium hyaluronate.
Sodium Hyaluronate Injection contains the active component 10 mg/mL of sodium hyaluronate and the excipients as follow: sodium chloride, disodium hydrogen phosphate and sodium dihydrogen phosphate.
CLINICAL PHARMACOLOGY
Characteristics
Sodium hyaluronate is a physiological substance that is widely distributed in the extracellular matrix of connective tissues in both animals and man. For example, it is present in the vitreous and aqueous humor of the eye, the synovialfluid, the skin and the umbilical cord. Sodium hyaluronates prepared from various human and animal tissues are not chemically different from each other.
Sodium Hyaluronate Injection is a specific fraction of sodium hyaluronate developed as an ophthalmo-surgical aid for use in anterior segment and vitreous procedures. It is specific in that:
1. It has a high molecular weight.
2. It is reported to be nonantigenic
3. It does not cause inflammatory or foreign body reactions.
4. It has a high viscosity.
Furthermore, the 1% solution of Sodium Hyaluronate Injection is transparent, is reported to remain in the anterior chamber for less than 6 days and protects corneal endothelial cells and other ocular structures. Sodium Hyaluronate Injection does not interfere with epithelialization and normal wound healing.
INDICATIONS AND USES
Sodium Hyaluronate Injection is indicated for use as an opthalmic surgical aid in cataract extraction (intra- and extracapsular), IOL implantation, corneal transplant, glaucoma filtration and retinal attachment surgery.
